Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines

Although the usefulness of the antimicrobial peptides known as defensins has been suggested against oral and skin infections, possible adverse effects of the defensins on the host should be understood before clinical applications can be contemplated. In the present study, we investigated how α-defen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dermatological science 2004-11, Vol.36 (2), p.87-95
Hauptverfasser: Nishimura, Michiko, Abiko, Yoshihiro, Kurashige, Yoshihito, Takeshima, Maiko, Yamazaki, Mami, Kusano, Kaoru, Saitoh, Masato, Nakashima, Keisuke, Inoue, Takashi, Kaku, Tohru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 95
container_issue 2
container_start_page 87
container_title Journal of dermatological science
container_volume 36
creator Nishimura, Michiko
Abiko, Yoshihiro
Kurashige, Yoshihito
Takeshima, Maiko
Yamazaki, Mami
Kusano, Kaoru
Saitoh, Masato
Nakashima, Keisuke
Inoue, Takashi
Kaku, Tohru
description Although the usefulness of the antimicrobial peptides known as defensins has been suggested against oral and skin infections, possible adverse effects of the defensins on the host should be understood before clinical applications can be contemplated. In the present study, we investigated how α-defensin (HNP-1) and β-defensins (hBD-1, -2, -3) affect cells including primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines, SCC-9 and KB. Cell proliferation was assessed by the direct cell counting and XTT assay. We found that α-defensin promotes proliferation of the epithelial cells at low concentration but has a cytotoxic effect at high concentration. In contrast, β-defensins have little effect on these cells at any concentration, suggesting that β-defensins may have no adverse effects on the host. Therefore, in terms of host response β-defensins may be more suitable antimicrobial agents for clinical applications than α-defensins.
doi_str_mv 10.1016/j.jdermsci.2004.07.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67034560</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923181104001343</els_id><sourcerecordid>67034560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-bba5a38e335858a85dbbfec40f31e098574eba1362f847e721951a38239407e3</originalsourceid><addsrcrecordid>eNqFkEFP3DAQhS1UBNuFv4B86qlJx3GcOD2BEC1ISFz2wM1ynLHwNomDnSD1wH-vt1nUY0_WeN6befMRcsUgZ8Cqb_t832EYonF5AVDmUOcA7IRsmKx5Jqrm-RPZQFPwjEnGzsnnGPcAIIqyOSPnTAjWMC435P3OWjQz9ZZ2aHGMbqQTTrPrMFI_Ulx-6fDbz85Qg30fv9MpuCF9UZzc_IK90_3a-Uqta4Nvex3nSPXY0fi66MEv8W-fGh2MG_2g17J3I8YLcmp1H_Hy-G7J7sfd7vY-e3z6-XB785iZUvI5a1stNJfIuZBCaim6tk2pS7CcITRS1CW2mvGqsLKssS5YI1gyFLwpoUa-JV_WsVPwrwvGWQ0uHlLoEVM-VdXAS1FBElar0AQfY0CrjtcqBurAXe3VB3d14K6gVol7Ml4dNyztgN0_2xF0ElyvAkxnvjkMKo3A0WDnQuKvOu_-t-MPUsOZvw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67034560</pqid></control><display><type>article</type><title>Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Nishimura, Michiko ; Abiko, Yoshihiro ; Kurashige, Yoshihito ; Takeshima, Maiko ; Yamazaki, Mami ; Kusano, Kaoru ; Saitoh, Masato ; Nakashima, Keisuke ; Inoue, Takashi ; Kaku, Tohru</creator><creatorcontrib>Nishimura, Michiko ; Abiko, Yoshihiro ; Kurashige, Yoshihito ; Takeshima, Maiko ; Yamazaki, Mami ; Kusano, Kaoru ; Saitoh, Masato ; Nakashima, Keisuke ; Inoue, Takashi ; Kaku, Tohru</creatorcontrib><description>Although the usefulness of the antimicrobial peptides known as defensins has been suggested against oral and skin infections, possible adverse effects of the defensins on the host should be understood before clinical applications can be contemplated. In the present study, we investigated how α-defensin (HNP-1) and β-defensins (hBD-1, -2, -3) affect cells including primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines, SCC-9 and KB. Cell proliferation was assessed by the direct cell counting and XTT assay. We found that α-defensin promotes proliferation of the epithelial cells at low concentration but has a cytotoxic effect at high concentration. In contrast, β-defensins have little effect on these cells at any concentration, suggesting that β-defensins may have no adverse effects on the host. Therefore, in terms of host response β-defensins may be more suitable antimicrobial agents for clinical applications than α-defensins.</description><identifier>ISSN: 0923-1811</identifier><identifier>EISSN: 1873-569X</identifier><identifier>DOI: 10.1016/j.jdermsci.2004.07.001</identifier><identifier>PMID: 15519138</identifier><language>eng</language><publisher>Netherlands: Elsevier Ireland Ltd</publisher><subject>alpha-Defensins - administration &amp; dosage ; alpha-Defensins - pharmacology ; Animals ; Antimicrobial peptide ; beta-Defensins - pharmacology ; Carcinoma, Squamous Cell - pathology ; Cell Count ; Cell culture ; Cell Division - drug effects ; Cell Line, Tumor ; Defensin ; Defensins ; Dose-Response Relationship, Drug ; Epithelial Cells - cytology ; Epithelial Cells - drug effects ; Fibroblasts - cytology ; Fibroblasts - drug effects ; Gingiva - cytology ; Host response ; Humans ; Oral ; Skin ; Swine</subject><ispartof>Journal of dermatological science, 2004-11, Vol.36 (2), p.87-95</ispartof><rights>2004 Japanese Society for Investigative Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-bba5a38e335858a85dbbfec40f31e098574eba1362f847e721951a38239407e3</citedby><cites>FETCH-LOGICAL-c483t-bba5a38e335858a85dbbfec40f31e098574eba1362f847e721951a38239407e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jdermsci.2004.07.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15519138$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nishimura, Michiko</creatorcontrib><creatorcontrib>Abiko, Yoshihiro</creatorcontrib><creatorcontrib>Kurashige, Yoshihito</creatorcontrib><creatorcontrib>Takeshima, Maiko</creatorcontrib><creatorcontrib>Yamazaki, Mami</creatorcontrib><creatorcontrib>Kusano, Kaoru</creatorcontrib><creatorcontrib>Saitoh, Masato</creatorcontrib><creatorcontrib>Nakashima, Keisuke</creatorcontrib><creatorcontrib>Inoue, Takashi</creatorcontrib><creatorcontrib>Kaku, Tohru</creatorcontrib><title>Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines</title><title>Journal of dermatological science</title><addtitle>J Dermatol Sci</addtitle><description>Although the usefulness of the antimicrobial peptides known as defensins has been suggested against oral and skin infections, possible adverse effects of the defensins on the host should be understood before clinical applications can be contemplated. In the present study, we investigated how α-defensin (HNP-1) and β-defensins (hBD-1, -2, -3) affect cells including primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines, SCC-9 and KB. Cell proliferation was assessed by the direct cell counting and XTT assay. We found that α-defensin promotes proliferation of the epithelial cells at low concentration but has a cytotoxic effect at high concentration. In contrast, β-defensins have little effect on these cells at any concentration, suggesting that β-defensins may have no adverse effects on the host. Therefore, in terms of host response β-defensins may be more suitable antimicrobial agents for clinical applications than α-defensins.</description><subject>alpha-Defensins - administration &amp; dosage</subject><subject>alpha-Defensins - pharmacology</subject><subject>Animals</subject><subject>Antimicrobial peptide</subject><subject>beta-Defensins - pharmacology</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Cell Count</subject><subject>Cell culture</subject><subject>Cell Division - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Defensin</subject><subject>Defensins</subject><subject>Dose-Response Relationship, Drug</subject><subject>Epithelial Cells - cytology</subject><subject>Epithelial Cells - drug effects</subject><subject>Fibroblasts - cytology</subject><subject>Fibroblasts - drug effects</subject><subject>Gingiva - cytology</subject><subject>Host response</subject><subject>Humans</subject><subject>Oral</subject><subject>Skin</subject><subject>Swine</subject><issn>0923-1811</issn><issn>1873-569X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEFP3DAQhS1UBNuFv4B86qlJx3GcOD2BEC1ISFz2wM1ynLHwNomDnSD1wH-vt1nUY0_WeN6befMRcsUgZ8Cqb_t832EYonF5AVDmUOcA7IRsmKx5Jqrm-RPZQFPwjEnGzsnnGPcAIIqyOSPnTAjWMC435P3OWjQz9ZZ2aHGMbqQTTrPrMFI_Ulx-6fDbz85Qg30fv9MpuCF9UZzc_IK90_3a-Uqta4Nvex3nSPXY0fi66MEv8W-fGh2MG_2g17J3I8YLcmp1H_Hy-G7J7sfd7vY-e3z6-XB785iZUvI5a1stNJfIuZBCaim6tk2pS7CcITRS1CW2mvGqsLKssS5YI1gyFLwpoUa-JV_WsVPwrwvGWQ0uHlLoEVM-VdXAS1FBElar0AQfY0CrjtcqBurAXe3VB3d14K6gVol7Ml4dNyztgN0_2xF0ElyvAkxnvjkMKo3A0WDnQuKvOu_-t-MPUsOZvw</recordid><startdate>20041101</startdate><enddate>20041101</enddate><creator>Nishimura, Michiko</creator><creator>Abiko, Yoshihiro</creator><creator>Kurashige, Yoshihito</creator><creator>Takeshima, Maiko</creator><creator>Yamazaki, Mami</creator><creator>Kusano, Kaoru</creator><creator>Saitoh, Masato</creator><creator>Nakashima, Keisuke</creator><creator>Inoue, Takashi</creator><creator>Kaku, Tohru</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041101</creationdate><title>Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines</title><author>Nishimura, Michiko ; Abiko, Yoshihiro ; Kurashige, Yoshihito ; Takeshima, Maiko ; Yamazaki, Mami ; Kusano, Kaoru ; Saitoh, Masato ; Nakashima, Keisuke ; Inoue, Takashi ; Kaku, Tohru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-bba5a38e335858a85dbbfec40f31e098574eba1362f847e721951a38239407e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>alpha-Defensins - administration &amp; dosage</topic><topic>alpha-Defensins - pharmacology</topic><topic>Animals</topic><topic>Antimicrobial peptide</topic><topic>beta-Defensins - pharmacology</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Cell Count</topic><topic>Cell culture</topic><topic>Cell Division - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Defensin</topic><topic>Defensins</topic><topic>Dose-Response Relationship, Drug</topic><topic>Epithelial Cells - cytology</topic><topic>Epithelial Cells - drug effects</topic><topic>Fibroblasts - cytology</topic><topic>Fibroblasts - drug effects</topic><topic>Gingiva - cytology</topic><topic>Host response</topic><topic>Humans</topic><topic>Oral</topic><topic>Skin</topic><topic>Swine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nishimura, Michiko</creatorcontrib><creatorcontrib>Abiko, Yoshihiro</creatorcontrib><creatorcontrib>Kurashige, Yoshihito</creatorcontrib><creatorcontrib>Takeshima, Maiko</creatorcontrib><creatorcontrib>Yamazaki, Mami</creatorcontrib><creatorcontrib>Kusano, Kaoru</creatorcontrib><creatorcontrib>Saitoh, Masato</creatorcontrib><creatorcontrib>Nakashima, Keisuke</creatorcontrib><creatorcontrib>Inoue, Takashi</creatorcontrib><creatorcontrib>Kaku, Tohru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatological science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nishimura, Michiko</au><au>Abiko, Yoshihiro</au><au>Kurashige, Yoshihito</au><au>Takeshima, Maiko</au><au>Yamazaki, Mami</au><au>Kusano, Kaoru</au><au>Saitoh, Masato</au><au>Nakashima, Keisuke</au><au>Inoue, Takashi</au><au>Kaku, Tohru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines</atitle><jtitle>Journal of dermatological science</jtitle><addtitle>J Dermatol Sci</addtitle><date>2004-11-01</date><risdate>2004</risdate><volume>36</volume><issue>2</issue><spage>87</spage><epage>95</epage><pages>87-95</pages><issn>0923-1811</issn><eissn>1873-569X</eissn><abstract>Although the usefulness of the antimicrobial peptides known as defensins has been suggested against oral and skin infections, possible adverse effects of the defensins on the host should be understood before clinical applications can be contemplated. In the present study, we investigated how α-defensin (HNP-1) and β-defensins (hBD-1, -2, -3) affect cells including primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines, SCC-9 and KB. Cell proliferation was assessed by the direct cell counting and XTT assay. We found that α-defensin promotes proliferation of the epithelial cells at low concentration but has a cytotoxic effect at high concentration. In contrast, β-defensins have little effect on these cells at any concentration, suggesting that β-defensins may have no adverse effects on the host. Therefore, in terms of host response β-defensins may be more suitable antimicrobial agents for clinical applications than α-defensins.</abstract><cop>Netherlands</cop><pub>Elsevier Ireland Ltd</pub><pmid>15519138</pmid><doi>10.1016/j.jdermsci.2004.07.001</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0923-1811
ispartof Journal of dermatological science, 2004-11, Vol.36 (2), p.87-95
issn 0923-1811
1873-569X
language eng
recordid cdi_proquest_miscellaneous_67034560
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects alpha-Defensins - administration & dosage
alpha-Defensins - pharmacology
Animals
Antimicrobial peptide
beta-Defensins - pharmacology
Carcinoma, Squamous Cell - pathology
Cell Count
Cell culture
Cell Division - drug effects
Cell Line, Tumor
Defensin
Defensins
Dose-Response Relationship, Drug
Epithelial Cells - cytology
Epithelial Cells - drug effects
Fibroblasts - cytology
Fibroblasts - drug effects
Gingiva - cytology
Host response
Humans
Oral
Skin
Swine
title Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts and squamous cell carcinoma cell lines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A09%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20defensin%20peptides%20on%20eukaryotic%20cells:%20primary%20epithelial%20cells,%20fibroblasts%20and%20squamous%20cell%20carcinoma%20cell%20lines&rft.jtitle=Journal%20of%20dermatological%20science&rft.au=Nishimura,%20Michiko&rft.date=2004-11-01&rft.volume=36&rft.issue=2&rft.spage=87&rft.epage=95&rft.pages=87-95&rft.issn=0923-1811&rft.eissn=1873-569X&rft_id=info:doi/10.1016/j.jdermsci.2004.07.001&rft_dat=%3Cproquest_cross%3E67034560%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67034560&rft_id=info:pmid/15519138&rft_els_id=S0923181104001343&rfr_iscdi=true